Related Funds
Fund Name | Location |
56.com | China, Guangdong, Guangzhou |
59store.com | China, Shanghai |
Baoguang Investment Management | China, Hangzhou, Zhejiang |
Becker Ventures | Grosse Pointe Park, Michigan, United States |
Central American Bank for Economic Integration (CABEI) | - |
Co.Builders | - |
Dundon Capital Partners | Dallas, Texas, United States |
eGlobe | India, Kerala, Trivandrum |
Fuse Venture Partners | England, London, United Kingdom |
Ghawi Capital LLC | - |
Global Logistic Properties | Central Region, Singapore, Singapore |
Lixil Group Corporation | Japan, Tokyo |
NewLake Capital Partners | Chicago, Illinois, United States |
Rainmaking | Copenhagen, Denmark, Hovedstaden |
The Hillman Company | Kelayres, Pennsylvania, United States |
Unknown Group | Rotterdam, The Netherlands, Zuid-Holland |
Wilmar International | Central, Central Region, Singapore |
Zhiji Equity Investment Management | China, Chongqing, Yubei |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Petra Pharma | $48M | 06 Jan 2016 | New York, United States | ||
Mersana Therapeutics | $27M | 31 Jul 2012 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Petra Pharma | $48M | 06 Jan 2016 | New York, United States | ||
Mersana Therapeutics | $27M | 31 Jul 2012 | Cambridge, Massachusetts, United States |